SAXENA NISHANT C enters CORBUS PHARMACEUTICALS HOLDINGS, INC. with 3.50K shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 5/22/2026ACC: 0001193125-26-237096
Officer· Chief Business Officer
Since May 2026
3.50K
Baseline shares
100% direct
3.50K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, par value $0.0001 per share
DirectShares owned3.50K
Total
3.50K direct3.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.0001 per share | 3.50K | Direct |
| Total | 3.50K | 3.50K direct |
Derivative Holdings0
No derivative holdings reported